We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+3.47%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$405B
AUM Growth
+$3.26B
Cap. Flow
-$4.73B
Cap. Flow %
-1.17%
Top 10 Hldgs %
17.59%
Holding
10,501
New
1,227
Increased
3,693
Reduced
4,131
Closed
1,043

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$1.12B
2
AAPL icon
Apple
AAPL
+$1.08B
3
MSFT icon
Microsoft
MSFT
+$1.05B
4
NKE icon
Nike
NKE
+$1.03B
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$821M

Sector Composition

Rank Sector Weight
1 Technology 17.8%
2 Financials 8.25%
3 Healthcare 6.4%
4 Consumer Discretionary 5.85%
5 Communication Services 4.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SEPZ icon
8276
TrueShares Structured Outcome September ETF
SEPZ
$129M
$2.8K ﹤0.01%
75
-24
-24% -$865
BROG
8277
DELISTED
Brooge Energy
BROG
$2.79K ﹤0.01%
+3,033
New +$3.33K
HCWB icon
8278
HCW Biologics
HCWB
$5.33M
$2.77K ﹤0.01%
18
+15
+500% +$4.43K
GNTA
8279
Genenta Science
GNTA
$68M
$2.77K ﹤0.01%
893
+852
+2,078% +$2.81K
ECML icon
8280
Euclidean Fundamental Value ETF
ECML
$126M
$2.77K ﹤0.01%
+87
New +$2.85K
VEGN icon
8281
US Vegan Climate ETF
VEGN
$180M
$2.76K ﹤0.01%
57
+56
+5,600% +$2.58K
WBIF icon
8282
WBI BullBear Value 3000 ETF
WBIF
$23M
$2.75K ﹤0.01%
+95
New +$2.81K
EQS icon
8283
Equus Total Return
EQS
$16.2M
$2.75K ﹤0.01%
2,081
+2,044
+5,524% +$2.94K
UEVM icon
8284
VictoryShares Emerging Markets Value Momentum ETF
UEVM
$252M
$2.74K ﹤0.01%
+56
New +$2.68K
DEEP icon
8285
Acquirers Small and Micro Deep Value ETF
DEEP
$28.2M
$2.71K ﹤0.01%
79
-406
-84% -$14.1K
EGRX
8286
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$2.7K ﹤0.01%
482
-11,707
-96% -$51K
BCTXW
8287
DELISTED
BriaCell Therapeutics Corp Warrant
BCTXW
$2.7K ﹤0.01%
+10,023
New +$7.21K
JPIB icon
8288
JPMorgan International Bond Opportunities ETF
JPIB
$2.11B
$2.69K ﹤0.01%
+57
New +$2.69K
SPRC icon
8289
SciSparc
SPRC
$4.1M
$2.68K ﹤0.01%
18
-29
-62% -$6.69K
BAMO icon
8290
Brookstone Opportunities ETF
BAMO
$46.4M
$2.67K ﹤0.01%
+92
New +$2.61K
NDIA icon
8291
Global X India Active ETF
NDIA
$59.6M
$2.67K ﹤0.01%
+86
New +$2.53K
SPMV
8292
DELISTED
Invesco S&P 500 Minimum Variance ETF
SPMV
$2.67K ﹤0.01%
61
+56
+1,120% +$2.39K
BOSC icon
8293
Better Online Solutions
BOSC
$31.8M
$2.66K ﹤0.01%
947
-1,499
-61% -$4.23K
NRXP icon
8294
NRX Pharmaceuticals
NRXP
$139M
$2.65K ﹤0.01%
1,087
-570
-34% -$2.03K
AUUD
8295
Auddia
AUUD
$5.47M
$2.64K ﹤0.01%
21
-67
-76% -$13.6K
IRAA
8296
DELISTED
Iris Acquisition Corp Class A Common Stock
IRAA
$2.64K ﹤0.01%
+236
New +$2.56K
JVA icon
8297
Coffee Holding Co
JVA
$19.4M
$2.63K ﹤0.01%
+1,125
New +$1.72K
QVOY
8298
Q3 All-Season Active Rotation ETF
QVOY
$59.1M
$2.63K ﹤0.01%
+95
New +$2.65K
AIFD
8299
TCW Artificial Intelligence ETF
AIFD
$132M
$2.63K ﹤0.01%
+94
New +$2.51K
LRHC icon
8300
La Rosa Holding
LRHC
$1.33M
0

Similar funds

UBS Group's Q2 2024 Portfolio in Review

As of Q2 2024, UBS Group held 10,501 positions worth $405B, up 0.81% from $402B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

UBS Group's Q2 2024 filing shows 1,227 new, 3,693 increased, 4,131 reduced and 1,043 closed positions. Its largest new stake was SLB Ltd: 10,925,731 shares worth $515M. The largest sale was BioMarin Pharmaceuticals, an estimated $389M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q2 2024 buy was SLB Ltd: 10,925,731 shares worth $515M.
  • UBS Group added most to NVIDIA in Q2 2024, an estimated $1.12B increase.
  • UBS Group's biggest Q2 2024 reduction was BioMarin Pharmaceuticals, cutting an estimated $389M.
  • UBS Group fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $263M.
  • UBS Group's ten largest holdings make up 18% of its $405B portfolio in Q2 2024.
  • UBS Group opened 1,227 new positions and closed 1,043 in Q2 2024.
  • UBS Group's portfolio value rose 0.81% quarter-over-quarter to $405B.

Based on UBS Group's 13F filing for Q2 2024, filed 14 Aug 2024.